Science | ABNewswire

Relapsing-Remitting Multiple Sclerosis Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Relapsing-Remitting Multiple Sclerosis Pipeline Insight 2025” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Relapsing-Remitting Multiple Sclerosis pipeline landscape. It covers the Relapsing-Remitting Multiple Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Oncolytic Virus Clinical Trial Pipeline Gains Momentum: 120+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Oncolytic Virus Cancer Therapy Pipeline Insight 2025” report provides comprehensive insights about 120+ companies and 125+ pipeline drugs in Oncolytic Virus Cancer Therapy pipeline landscape. It covers the Oncolytic Virus Cancer Therapy pipeline drug profiles, including clinical and non-clinical … Continue reading →

Scleroderma Clinical Trial Pipeline Expands as 40+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Scleroderma Pipeline Insight 2025” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in Scleroderma pipeline landscape. It covers the Scleroderma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Scleroderma pipeline therapeutics … Continue reading →

Relapsed/Refractory Acute Myeloid Leukemia Clinical Trial Pipeline Shows Potential with Active Contributions from 50+ Key Companies | DelveInsight

DelveInsight’s, “Relapsed/refractory acute myeloid leukemia Pipeline Insight 2025” report provides comprehensive insights about 50+ companies and 75+ pipeline drugs in the Relapsed/refractory acute myeloid leukemia (AML) pipeline landscape. It covers the Relapsed/Refractory Acute Myeloid Leukemia pipeline drug profiles, including clinical … Continue reading →

ANCA Vasculitis Pipeline Shows Strong Momentum as 12+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “ANCA Vasculitis Pipeline Insight 2025” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the ANCA Vasculitis pipeline landscape. It covers the ANCA Vasculitis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Atom Edge Wins Xero Beautiful Business Fund for Innovative 3D Anatomy Model

Atom Edge, a South African technology company specialising in anatomically accurate 3D anatomy models, has been named a country winner of the 2024 Xero Beautiful Business Fund. The award recognises its high-precision digital anatomy model used in software, design, and … Continue reading →

The End of the “Latin Courier”: aiomics Reinvents the Patient Letter as a Personalized Health Manual

“For too long, the discharge letter has treated the patient as a courier—carrying a sealed document of Latin jargon to a GP they cannot reach. AI allows us to finally write for the patient, transforming a clinical handover into a … Continue reading →

Ocemida Nexis Ranks Highest in Independent Hydrogen Water Bottle Testing

Ocemida Nexis (6000-PRO) Flagship device delivers laboratory-grade hydrogen concentrations for performance-focused consumers and researchers alike Ocemida, a Canadian innovator in molecular hydrogen technology, today announced that its flagship Ocemida Nexis has achieved the highest hydrogen concentration recorded by H2Hubb for … Continue reading →

Waveguard Identified as a Leading Provider of Scientifically Backed EMF Protection Devices for Modern Wired Lifestyles

SALT LAKE CITY, UT – Feb 2, 2026 – Waveguard, a technology company rooted in German engineering and independent scientific research, has been recognized as a leading provider of consumer electromagnetic field (EMF) protection devices designed to help individuals and families … Continue reading →

Data Index finds UK AI hiring shifting from R&D toward product and operations

UK job listings on Data Index show AI roles moving from R&D to product and operations, with emphasis on integration, testing and monitoring. Review of job listing language indexed on Data Index suggests UK employers are shifting AI hiring toward … Continue reading →

Thursday - February 05, 2026

Category Archives: Science